Home » Topics » BioWorld Science

BioWorld Science
RSS

MG-1131, a novel anti-TIGIT monoclonal antibody with promising in vitro efficacy

Nov. 14, 2019

Urinary TIMP2 and IGFBP7 as early biomarkers to predict drug induced AKI

Nov. 14, 2019

First-in-human data for ASN-007 presented

Nov. 14, 2019

First patient dosed in phase I/II study of the bicycle toxin conjugate BT-5528

Nov. 14, 2019

Results from multiple phase III studies of anemia treatment roxadustat presented

Nov. 14, 2019

Mouse-human chimeric anti-CXADR antibody shows antitumor activity in prostate and SCLC models

Nov. 14, 2019

First-in-class fusion inhibitor against diverse and multidrug-resistant HCV strains presented

Nov. 14, 2019

SHR-4640: a potential new hyperuricemia treatment option

Nov. 14, 2019

Diabetes drug eases nicotine withdrawal

Nov. 14, 2019

TFEB initiates fat cell browning

Nov. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...